Belgium· BE-AMP-SAM131171-00
Gastricalm 400 mg
A magaldrate product containing magaldrate, registered in Belgium by Novum Pharma. The same ATC class is registered in 6 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Magaldrate is registered in 6 of 19 countries.
Countries holding a registration under ATC A02AD02 (magaldrate), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 4 of them publish a price we can compare per daily dose
Magaldrate · ATC A02AD02
6 / 19 countries
- Belgiumprice
- Finlandprice
- Germany
- Italyprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of magaldrate costs, country by country.
Normalised to the WHO defined daily dose (3.2 g), the median price runs from $0.54 in Italy to $1.43 in Switzerland — a ×2.6 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Magaldrate · price per daily dose (3.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.43
- IT Italy$0.54
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Magaldrate
- Manufacturer
- Novum Pharma
- Country
- Belgium (BE)
- ATC code
- A02AD02
- ATC class
- Magaldrate
- Defined daily dose
- 3.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb1097526
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
223 interactions on record for magaldrate.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Magaldrate · interactions on record
223 records
- 8 severe
- 106 moderate
- 93 minor
Most severe, free to view
- RaltegravirJ05AJ01severe
- DolutegravirJ05AJ03severe
- RaltegravirJ05AX08severe
- DolutegravirJ05AX12severe
16 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Magaldrate in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- ItalyGADRALNEOPHARMED GENTILI S.P.A.
- SwitzerlandRiopan 800 mg, TablettenTakeda Pharma AG
- GermanyMagaldrat RatiopharmRatiopharm Gmbh
- SpainBEMOLAN 2000 mg GEL ORALTakeda Farmaceutica Espana S.A.
- United KingdomBisodol Extra tabletsForest Laboratories UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Austria · Riopan
- Germany · Magaldrat Ratiopharm, Riopan Btl
- Spain · Bemolan, Magión
- Greece · Riopan
- Italy · Gadral, Magaldrato Doc
- Luxembourg · Riopan
- Portugal · Riopan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/11d5e242-978e-45d2-aa5c-96d276e3691a GET /v1/drugs/11d5e242-978e-45d2-aa5c-96d276e3691a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Chewable tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Gastricalm 400 mg",
"name_fr": "Gastricalm 400 mg",
"name_nl": "Gastricalm 400 mg",
"amp_code": "SAM131171-00",
"strengths": [
"400.0000",
"400.0000",
"50.0000",
"100.0000"
],
"pack_count": 3,
"substances": [
"Magaldrate",
"Mannitol",
"Sucrose"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Magaldrate",
"authorisation_numbers": [
"BE131171"
]
}See everything about magaldrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.